# Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer

> **NCT07023484** · PHASE2 · RECRUITING · sponsor: **The University of Hong Kong** · enrollment: 126 (estimated)

## Conditions studied

- Ovarian Cancer
- Fallopian Tube Cancer
- Primary Peritoneal Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** KELIM
- **DRUG:** Carboplatin plus Paclitaxel
- **PROCEDURE:** Interval debulking surgery

## Key facts

- **NCT ID:** NCT07023484
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-22
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2025-07-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07023484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07023484, "Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07023484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*